Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany

Langenbeck's Archives of Surgery

Volumn 384, Issue 1, 1999, Pages 54-59

  Mayr, B ^a   Potter E ^a   Goretzki, P ^b   Ruschoff J ^c   Dietmaier, W ^c   Hoang Vu, C ^d   Dralle, H ^d   Brabant, G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Ret protooncogene; Ret PTC oncogene; Thyroid papillary carcinoma

Indexed keywords

COMPLEMENTARY DNA; RNA; SINGLE STRANDED DNA;

ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE RET; PRIORITY JOURNAL; PROTO ONCOGENE; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA;

CARCINOMA, PAPILLARY; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; THYROID NEOPLASMS; VARIATION (GENETICS);

EID: 0345620970     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050174     Document Type: Article

References (30)

1. Belfiore A, Gangemi P, Costantino A, et al. (1997) Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab 82:2322-2328
2. Bongarzone I, Monzini N, Borrello MG, et al. (1993) Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Biol 13:358-366
3. Bongarzone I, Fugazzola L, Vigneri P, et al. (1996) Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab 81:2006-2009
4. Buj-Bello A, Adu J, Pinon LG, et al. (1997) Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase Nature 387:721-724
5. Fabien N, Paulin C, Santoro M, et al. (1992) Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation. Br J Cancer 66:1094-1098
6. Fugazzola L, Pierotti MA, Vigano E, Pacini F, Vorontsova TV, Bongarzone I (1996) Molecular and biochemical analysis, of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene 13:1093-1097
7. Grieco M, Santoro M, Berlingieri MT, et al. (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557-563
8. Ishizaka Y, Ushijima T, Sugimura T, Nagao M. (1990) cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. Biochem Biophys Res Commun 168:402-408
9. Jhiang SM, Sagartz JE, Tong Q, et al. (1996) Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137:375-378
10. Jing S, Wen D, Yu Y. et al. (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113-1124
11. Jossart GH, Epstein HD, Shaver JK, et al. (1996) Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines. J Clin Endocrinol Metab 81:3498-3504
12. Klein RD, Sherman D, Ho WH, et al. (1997) A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor Nature 387:717-721
13. Klugbauer S. Lengfelder E, Demidchik EP, Rabes HM (1996) A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident. Oncogene 13:1099-1102
14. Mayr B, Brabant G, Goretzki P, Ruschoff J, Dietmaier W, Dralle H (1997) ret/PTC-1. -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab 82:1306-1307
15. Pierotti MA, Bongarzone I, Borrello MG, et al. (1995) Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas. J Endocrinol Invest 18:130-133
16. Rochefort P, Caillou B, Michiels FM, et al. (1996) Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene 12:111-118
17. Santoro M, Carlomagno F, Hay ID, et al. (1992) Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Endocrinol Invest 89:1517-1522
18. Santoro M, Sabino N, Ishizaka Y, et al. (1993) Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Br J Cancer 68:460-464
19. Santoro M, Dathan NA, Berlingieri MT, et al. (1994) Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene 9:509-516
20. Santoro M, Chiappetta G, Cerrato A, et al. (1996) Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12:1821-1826
21. Scheumann GF, Hoang Vu C, Cetin Y, et al. (1995) Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. J Clin Endocrinol Metab 80:2168-2172
22. Shi Y, Zou M, Farid NR, al Sedairy ST (1996) Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas. Br J Cancer 74:1336-1341
23. Sugg L, Zheng L, Rosen I, Freeman J, Ezzat S, Asa S (1996) ret/PTC-1, -2, and -3 oncogene rearrangement in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab 81:3360-3365
24. Treanor JJ, Goodman L, de Sauvage F, et al. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382:80-83
25. Trupp M, Arenas E, Fainzilber M, et al. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381:785-788
26. von Wasielewski R, Rhein A, Werner M, et al. (1997) Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. Cancer Res 57:2501-2507
27. Williams GH, Rooney S, Thomas GA, Cummins G, Williams ED. (1996) RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br J Cancer 74:585-589
28. Wynford Thomas D (1997) Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. Horm Res 47:145-157
29. Zedenius J, Wallin G, Hamberger B, Nordenskjold M, Weber G, Larsson C (1994) Somatic and MEN 2A de novo mutations identified in the RET protooncogene by screening of sporadic MTCs. Hum Mol Genet 3:1259-1262
30. Zou M, Shi Y, Farid NR. (1994) Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer 73:176-180